Shringkhala B.

Study Director / Senior Scientist at Minaris Advanced Therapies

Shringkhala B. holds a PhD in Virology from the University of Rochester School of Medicine and Dentistry and a Bachelor of Science in Biology from Salem College. Currently, Shringkhala B. serves as a Study Director and Senior Scientist at Minaris Advanced Therapies and as an AI Model Trainer with a focus on Virology at Pareto.AI since March 2025. Previous experience includes various roles at Advanced Therapies, LLC, where Shringkhala B. progressed from Associate Scientist to Study Director in Virology Operations. Additionally, Shringkhala B. worked as a COVID-19 Disease Investigator for Kindred Healthcare and the Kentucky Department for Public Health, and held research positions at prestigious institutions such as the University of Rochester and Beth Israel Deaconess Medical Center.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Minaris Advanced Therapies

1 followers

Minaris Advanced Therapies is a global contract development and manufacturing organization (CDMO) and contract testing provider focused exclusively on cell and gene therapies. Minaris Advanced Therapies is headquartered in Philadelphia, Pennsylvania, and has more than 730,000 square feet of infrastructure across the United States, Europe and Asia. We have manufactured and released over 7,500 GMP batches and our global network supports therapy developers through early-stage development, clinical trials and commercial manufacturing. By combining scientific expertise with best-in-class manufacturing and testing services, we help bring safe, effective therapies to patients faster and more efficiently. With more than 20 years’ experience in the field of regenerative medicine, we are trusted partner ensuring scalability, delivering high quality results, and achieving cost effective manufacturing. Our state-of-the-art facilities in the United States, Europe, and Asia, as well as our committed employees, enable us to supply patients worldwide with lifechanging therapies. Minaris Advanced Therapies is wholly owned by Altaris, LLC.


Employees

1,001-5,000

Links